ResMed | RMD - La Marge Brute Sur Les Ventes





La Marge Brute Sur Les Ventes Changement Date
Ansell USD 326.2M 27.6M 2024-06
Artivion USD 73.14M 1.25M 2025-12
AtriCure USD 109.31M 3.97M 2026-03
Baxter International USD 891M 314M 2026-03
Cochlear AUD 856.8M 430M 2025-12
Cooper Companies USD 735.4M 40.2M 2026-03
CSL USD 4.46B 2.71B 2025-12
Dexcom USD 750.3M 42.4M 2026-03
Edwards Lifesciences USD 1.35B 62.6M 2026-06
Fisher Paykel Healthcare NZD 784.4M 98.7M 2026-06
Globus Medical USD 496.26M 39.69M 2026-03
Haemonetics USD 202.39M 7.64M 2025-12
Idexx Laboratories USD 722.74M 64.62M 2026-03
Inogen USD 41.34M 1.39M 2024-09
Insulet USD 540.8M 27.8M 2026-03
Integra LifeSciences USD 213.21M 3.89M 2026-03
Intuitive Surgical USD 2.02B 193.4M 2026-06
Medtronic USD 6.01B 595M 2026-03
Philips EUR 1.77B 522M 2026-03
Ramsay Health Care AUD 549.95M 5.77B 2025-06
ResMed USD 890.98M 12.26M 2026-03
Sigma Healthcare AUD 160.13M 10.55M 2024-07
Sonic Healthcare AUD 3.92B 3.14B 2024-12
Steris USD 655.5M 9.6M 2025-12
Teleflex USD 307.43M 21K 2026-03
Thermo Fisher Scientific USD 4.49B 146M 2026-03